Vulvar Cancer Pipeline Insight 2024, with Key Focus on TAK-242, Vudalimab, PEN-866, Artesunate, IRX-2, ISA101, VicOryx, PRV111, PRGN-2009, ABI-2280 and CUE-101
April 16, 2024 12:46 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Vulvar Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029: 800+ Bispecific Candidates Currently in Active Clinical Development
March 18, 2024 05:16 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Market, Drugs Sales, Patent, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
$7.25 Bn Antibody Fragments Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts to 2028
January 15, 2024 08:58 ET
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Bispecific Antibody Competitive Landscape Report Unveils Comprehensive Insights on Therapeutics Assessment and Growth Dynamics in the Global Market
December 21, 2023 09:48 ET
|
Research and Markets
Dublin, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The "Bispecific antibody - Competitive landscape, 2023" report has been added to ResearchAndMarkets.com's offering. Amidst rapid advancements in the...
Folate Receptor Alpha Targeted Therapies - Exciting Advancements in Oncological R&D Revealed in Comprehensive Pipeline Review
December 14, 2023 05:28 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy Pipeline Review" report has been added to ResearchAndMarkets.com's offering. This pipeline review...
Global CD19 Antibody Market Projected to Exceed $10 Billion by 2028, Driven by Promising Pipeline of Therapies
November 09, 2023 05:58 ET
|
Research and Markets
Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market & Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19...
The Global Market for Bispecific Antibody Therapeutics Contract Manufacturing 2023-2030: Driven by Demand for Innovative Therapies and Promising Results Seen in Clinical Development
November 06, 2023 09:04 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Bispecific Antibody Therapeutics Contract Manufacturing Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The...
China Bispecific Antibodies Market and Clinical Pipeline Insight Report 2023-2028: Akeso are Leading the Way and Gaining Global Recognition for their Innovative Clinical Candidates
November 06, 2023 04:23 ET
|
Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "China Bispecific Antibodies Market and Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The...
Global CD19 Antibody Market Set to Surpass $10 Billion by 2028: A Revolutionary Era in Immunotherapy
November 03, 2023 07:43 ET
|
Research and Markets
Dublin, Nov. 03, 2023 (GLOBE NEWSWIRE) -- The "Global CD19 Antibody Market and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The global CD19 Antibody...
United States Bispecific Antibodies Market & Clinical Pipeline Research Report 2023: Potential Market Opportunity of $15 Billion By 2028 - Dosage, Price and Sales Insights
October 16, 2023 07:03 ET
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The US...